Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/2012
05/31/2012CA2818814A1 Anti-il-6 antibodies for the treatment of anemia
05/31/2012CA2818813A1 Anti-il-6 antibodies for the treatment of oral mucositis
05/31/2012CA2818712A1 Compositions and methods for treating or preventing lupus
05/31/2012CA2818671A1 Stable preserved compositions of interferon-beta
05/30/2012EP2457930A1 Modified chaperonin 10
05/30/2012EP2457896A1 Tripeptides as caspase modulators
05/30/2012EP2457895A1 Tetrapeptide analogs
05/30/2012EP2457590A2 Protein formulation
05/30/2012EP2457585A1 Methods for treating conditions associated with MASP-2 dependent complement activation
05/30/2012EP2457582A1 Method and compositions for controlling ectoparasites
05/30/2012EP2457581A1 Composition for external preparation for skin
05/30/2012EP2457580A1 Absorption enhancers for drug administration
05/30/2012EP2457579A1 Covalently linked interleukin -10
05/30/2012EP2457578A1 Chimeric molecule comprising angiopoietin-1 and a coiled-coil domain for use in treating penile erectile dysfunction
05/30/2012EP2457577A1 Diphtheria toxin variant
05/30/2012EP2457564A1 Controlled release formulations of octreotide
05/30/2012EP2456785A1 Vaccines based on genetic chimera of viral and/or tumoral antigens and vegetable proteins
05/30/2012EP2456457A1 Compounds which inhibit muscle contraction
05/30/2012EP2456456A1 Methods and compositions for treating neuronal damage or degeneration
05/30/2012EP2456455A1 Compositions and methods of use for post-radiation protection
05/30/2012EP2456454A1 Polypeptides selective for av 3 integrin conjugated with a variant of human serum albumin (hsa) and pharmaceutical uses thereof
05/30/2012EP2456448A1 Methods of attenuating the loss of functional status
05/30/2012EP2188308B1 High yield secretion of multimeric recombinant protein
05/30/2012EP2078531B1 Pharmaceutical compositions and methods useful for modulating angiogenesis
05/30/2012EP2021365B1 A ghrelin splice variant for use in the prevention or treatment of high cholesterol levels
05/30/2012EP1999146B1 Use of ghrelin splice variant for treating cachexia and/or anorexia and/or anorexia-cachexia and/or malnutrition and/or lipodystrophy and/or muscle wasting and/or appetite stimulation
05/30/2012EP1994939B1 Pharmaceutical composition containing GHRP-6 for preventing and eliminating fibrosis and other pathological deposits in tissue
05/30/2012EP1960422B1 Potent compstatin analogs
05/30/2012EP1928551B1 Methods to reduce oxalate concentration by administration of oxalate oxidase crystals
05/30/2012EP1843783B1 Control of drug release by transient modification of local microenvironments
05/30/2012EP1405079B1 Modulation of the interaction between evh1 domains
05/30/2012EP1366149B1 Modified target enzymes having catalytic triads and uses thereof
05/30/2012EP1283057B2 Cell proliferation inhibitors
05/30/2012EP1263465B1 Photodynamic cellular organism eradication using a photosensitive material and surfactant
05/30/2012EP1176193B1 Inhibitors for viral infection targeting integrase n-terminal region
05/30/2012CN1997386B Methods of treating type I diabetes by blocking VEGF-mediated activity
05/30/2012CN1985000B T-cell death-inducing epitopes
05/30/2012CN1919873B Fusion albumen containing HSP70 ATPase structure field and mammal p53 albumen and application thereof
05/30/2012CN1901930B Integrin alphaiibbeta3 specific antibodies and peptides
05/30/2012CN1871258B Fusion polypeptides, and use thereof in antivascular tumor therapy
05/30/2012CN1852730B Modulators of P-selectin glycoprotein ligand 1
05/30/2012CN1703238B Recombinant intracellular pathogen immunogenic compositions and methods for use
05/30/2012CN1692124B P53 binding T cell receptor molecules and uses thereof
05/30/2012CN102482664A Marker for predicting therapeutic effect on hepatitis c, method for predicting therapeutic effect on hepatitis c, and prophylaxis or therapeutic agent for hepatitis c
05/30/2012CN102482351A Anti-c[epsilon]mx antibodies capable of binding to human mige on b lymphocytes
05/30/2012CN102482341A 纯化vwf以增加非-脂质包封的病毒的去除 Purified to increase the non-vwf - removing lipid encapsulated viruses
05/30/2012CN102482340A Targeted delivery of factor viii proteins to platelets
05/30/2012CN102482339A Methods for increasing thermogenic adipocytes
05/30/2012CN102482338A Variants of plasminogen and plasmin
05/30/2012CN102482337A 吡咯啉-5-羧酸还原酶1的突变蛋白 Pyrroline-5-carboxylate reductase 1 mutant proteins
05/30/2012CN102482332A 用于获得肉毒杆菌神经毒素的方法和系统 Botulinum neurotoxin used to obtain a method and system for
05/30/2012CN102482325A Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles
05/30/2012CN102482323A 新型肽及其应用 Novel peptide and its application
05/30/2012CN102481369A 抗革兰氏阴性菌剂 Against gram-negative bacterium
05/30/2012CN102481346A 新颖的翻译后纤维蛋白原变体 Novel post-translational variants of fibrinogen
05/30/2012CN102481345A 精氨酸酶的定向位点聚乙二醇化及其作为抗癌和抗病毒试剂的用途 Arginase site-directed pegylation and as anti-cancer and anti-viral agents use
05/30/2012CN102481344A 具有纤溶亢进的凝血病的治疗 Treatment of hyperthyroidism with a fibrinolytic coagulopathy
05/30/2012CN102481343A 稳定的含胰岛素的非水液体药物组合物 Stability of the insulin-containing non-aqueous liquid pharmaceutical composition
05/30/2012CN102481342A 使用促皮质素释放因子治疗癌症的方法 Use corticotropin releasing factor method of treating cancer
05/30/2012CN102481341A Proproteins and methods of use thereof
05/30/2012CN102481340A 干细胞靶向 Stem cell targeting
05/30/2012CN102481339A 用作药物的能够恢复肌肉强度的修饰的聚集蛋白片段 Can restore the muscle strength of the modified aggregated protein fragments as a medicament
05/30/2012CN102481338A Glycomacropeptide medical foods for nutritional management of phenylketonuria and other metabolic disorders
05/30/2012CN102481337A 用于治疗糖尿病的调节mg29的组合物和方法 Compositions and methods for treating diabetes for adjusting mg29
05/30/2012CN102481336A 从棘白菌素C<sub>0</sub>中分离和/或提纯棘白菌素B<sub>0</sub> From Echinocandin C <sub> 0 </ sub> separation and / or purification Echinocandin B <sub> 0 </ sub>
05/30/2012CN102481335A 生殖器功能、性功能和生殖功能的刺激物 Genital function, sexual function and reproductive function of stimulus
05/30/2012CN102481334A Prodrug Anti-cancer Therapy
05/30/2012CN102481333A Immunity inducer
05/30/2012CN102481332A Peptide therapy for increasing platelet levels
05/30/2012CN102481331A 葡萄糖调节多肽及其制备和使用方法 Glucose-regulating peptide and its preparation and use
05/30/2012CN102481330A C型利钠肽变体 C-type natriuretic peptide variants
05/30/2012CN102481309A 包含脂质体包胶的寡核苷酸和表位的免疫刺激性组合物 Immunostimulatory oligonucleotides and compositions containing the epitope encapsulated liposomes
05/30/2012CN102481307A 使用抗菌氨基糖苷化合物治疗肺炎克雷伯杆菌感染 The use of antimicrobial compounds for the treatment of aminoglycoside Klebsiella pneumoniae infection
05/30/2012CN102481276A Chemosensory receptor ligand-based therapies
05/30/2012CN102481255A Particle composition and medicinal composition comprising same
05/30/2012CN102481254A Method and pharmaceutical compositions for trans-buccal mucosa treatment of postprandial hyperglycaemia in type ii diabetes
05/30/2012CN102481251A Ipamorelin diacetate injection and infusion solutions
05/30/2012CN102477444A 一种细胞骨架结合蛋白wdr1基因敲除模型的建立及其用途 A cytoskeletal protein binding to establish their uses wdr1 knockout models
05/30/2012CN102477422A 一种重组人甲状旁腺激素的制备方法 A recombinant human parathyroid hormone preparation
05/30/2012CN102477421A 一种激酶蛋白Akt1基因条件性敲除小鼠的建立及用途 A protein kinase Akt1 gene conditional knockout mice to establish and use
05/30/2012CN102477093A 一种热稳定人角质细胞生长因子突变体的制备方法及其应用 A heat-stable human keratinocyte growth factor preparation method and its application mutants
05/30/2012CN102477085A 白念珠菌生长相关因子Cas5突变体的构建和应用 Candida albicans growth-related factor Cas5 mutation body construction and application
05/30/2012CN102477084A 链长为59的聚天冬酰-l-赖氨酸及其制备方法和应用 A chain length of 59 -l- polyaspartic acid lysine and its preparation method and application
05/30/2012CN102477081A 一种新型多肽在干燥综合征诊断中的应用 A novel peptide used in the diagnosis of Sjogren's syndrome
05/30/2012CN102477080A 一种新型多肽在类风湿关节炎诊断中的应用 A novel peptide used in the diagnosis of rheumatoid arthritis
05/30/2012CN102477079A 一种新型多肽在系统性红斑狼疮诊断中的应用 A novel peptide used in the diagnosis of systemic lupus erythematosus
05/30/2012CN102477078A 胸腺体液因子(THF)-γ2改构肽的制备及其药物组合物的用途 Preparation and use of pharmaceutical compositions thymic humoral factor (THF) -γ2 the altered peptide
05/30/2012CN102477077A Boc-Pro-Ala-Lys-Lys(Pro-Ala-Lys)-OCH<sub>2</sub>(CH<sub>2</sub>)nCH<sub>3</sub>、其合成和作为溶血栓剂的应用 Boc-Pro-Ala-Lys-Lys (Pro-Ala-Lys) -OCH <sub> 2 </ sub> (CH <sub> 2 </ sub>) nCH <sub> 3 </ sub>, its synthesis and As the application of thrombolytic agents
05/30/2012CN102477076A Oligopeptide compound for thrombolysis, its preparation method and application
05/30/2012CN102477075A 用于抗血栓的寡肽及其制备方法和应用 For antithrombotic oligopeptide and its preparation method and application
05/30/2012CN102477074A 寡肽化合物及其制备方法和应用 Oligopeptide compound and its preparation method and application
05/30/2012CN102477073A 具有溶血栓活性的寡肽及其制备方法和应用 Oligopeptide and its preparation method and application having thrombolytic activity
05/30/2012CN102477072A 用于溶血栓的寡肽化合物及其制备方法和应用 Compounds used in its preparation method and application of thrombolytic oligopeptide
05/30/2012CN102477071A Pro-Ala-Lys-Lys(Pro-Ala-Lys)-Asp[OCH2(CH2)nCH3]-OCH2(CH2)nCH3, synthesis method and application thereof as thrombus dissolving agent
05/30/2012CN102477070A 具有溶血栓活性的寡肽及其制备方法和应用 Oligopeptide and its preparation method and application having thrombolytic activity
05/30/2012CN102477069A Pro-Ala-Lys-Asp[OCH<sub>2</sub>(CH<sub>2</sub>)nCH<sub>3</sub>]-OCH<sub>2</sub>(CH<sub>2</sub>)nCH<sub>3</sub>、及其合成和作为溶血栓剂的应用 Pro-Ala-Lys-Asp [OCH <sub> 2 </ sub> (CH <sub> 2 </ sub>) nCH <sub> 3 </ sub>] - OCH <sub> 2 </ sub> (CH Applications <sub> 2 </ sub>) nCH <sub> 3 </ sub>, its synthesis and as a thrombolytic agent
05/30/2012CN102477068A 用于制备溶血栓药物的氨基酸衍生物及其制备方法和应用 Amino acid derivative and its preparation method and application for the preparation of thrombolytic drugs
05/30/2012CN102477067A 3-氨基-2-羟基-4-苯基-缬氨酰-异亮氨酸及其制备方法和应用 3-amino-2-hydroxy-4-phenyl - valyl - isoleucine and its preparation method and application
05/30/2012CN102477066A N-(s-1,2,3,4-四氢-6,7-二羟基异喹啉-3-甲酰)氨基酸及其合成方法和应用 N- (s-1,2,3,4- tetrahydro-6,7-dihydroxy-isoquinoline-3-carboxylic acid) amino acids and the synthesis method and application
05/30/2012CN102475893A Method for treating human malignant solid tumor by using hepatocyte nuclear factor-1alpha
1 ... 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 ... 3163